Scott D. Solomon

Recommendations for Chamber Quantification: A Report from the American Society of Echocardiography’s Guidelines and Standards Committee and the Chamber Quantification Writing Group, Developed in Conjunction with the European Association of Echocardiography, a Branch of the European Society of Cardiology

Guidelines for the Echocardiographic Assessment of the Right Heart in Adults: A Report from the American Society of Echocardiography

Angiotensin–Neprilysin Inhibition versus Enalapril in Heart Failure

Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction

Cardiac-Resynchronization Therapy for the Prevention of Heart-Failure Events

Patisiran, an RNAi Therapeutic, for Hereditary Transthyretin Amyloidosis

Spironolactone for Heart Failure with Preserved Ejection Fraction

Dapagliflozin in Heart Failure with Mildly Reduced or Preserved Ejection Fraction

Valsartan, Captopril, or Both in Myocardial Infarction Complicated by Heart Failure, Left Ventricular Dysfunction, or Both

Angiotensin–Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction

Lixisenatide in Patients with Type 2 Diabetes and Acute Coronary Syndrome

Renin–Angiotensin–Aldosterone System Inhibitors in Patients with Covid-19